BBIO: BridgeBio Pharma Inc Company Profile & Statistics

About

BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.

Info & Links

CEO

Neil Kumar

Headquarters

3160 PORTER DR., SUITE 250
PALO ALTO, CA 94304, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

550

BridgeBio Pharma Inc Statistics

Valuation Measures

Market Capitalization²

4.91B

Enterprise Value

6.23B

Enterprise Value/EBITDA(ttm)

-11.57

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

23.86

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

78.99%

Operating Margin(ttm)

-243.68%

Profit Margin(ttm)

-4743.01%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-94.43%

Return on Assets(ttm)

-74.34%

Income Statement

Revenue(ttm)

217.76M

Revenue Per Share(ttm)

1.15

Gross Profit(ttm)

215.37M

EBITDA(ttm)³

-538.07M

Net Income Available to Common(ttm)

-438.86M

Diluted EPS(ttm)

-2.41

Share Statistics

Beta (5Y Monthly)

1.08

52-Week Change

-18.60%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

188.99M

Dividend Yield

0.00%

Float⁴

142.38M

% Held by Insiders

24.66%

% Held by Institutions

99.85%

Balance Sheet

Total Cash(mrq)

405.73M

Total Cash Per Share(mrq)

2.15

Total Debt(mrq)

1.72B

Total Debt/Equity(mrq)

-141.04%

Current Ratio(mrq)

3.19%

Quick Ratio(mrq)

3.19%

Book Value Per Share(mrq)

-6.45

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.73

Free Cash Flow(ytd)

-326.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BBIO

BridgeBio Pharma Inc

BridgeBio Pharma Inc Profile